MiR-181b suppresses the progression of epilepsy by regulation of lncRNA ZNF883.

CONCLUSION: MiR-181b suppressed the progression of epilepsy via regulation of RASSF1A and lncRNA ZNF883. Thus, miR-181b might serve as a new target for treatment of EP. PMID: 32655808 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32655808?dopt=Abstract

Source: American Journal of Translational Research - July 15, 2020 Category: Research Tags: Am J Transl Res Source Type: research